Dr. Wang completed his medical degree at the Central South University Xiangya Medical School in China and his Ph.D in neurobiology at the University of Connecticut. He completed a neurology residency at the University of Vermont, and a clinical fellowship in epilepsy at the University of Michigan.
Dr. Wang’s primary clinical interests involve the medical and surgical treatment of refractory epilepsy, MRI-negative epilepsy and pharmacology of anti-seizure medications. Dr. Wang believes that the ultimate goal of epileptologists is to improve patient’s quality of life and restore his or her self-confidence. This can be accomplished by knowledge and theory in epilepsy on one hand and practical wisdom on the other.
Dr. Wang’s current research interests focus on epilepsy genetics and brain development with the goals that these studies will transform our understanding in the mechanism of epilepsy and pave ways to therapeutic development. He is using genome editing methods and induced pluripotent stem cells (iPSCs) to dissect the abnormal network in epileptic brains and to develop effective therapies.
Medical and surgical treatment of epilepsy
Medical School or Training
- Xiangya Medical School, Central South University, 2000
- University of Vermont/Fletcher Allen Health Care, Neurology, VT, 2013
- Clinical Neurophysiology, University of Michigan, 2014